-
Parkinson's Disease May Originate in Gut, Study Says
drugs.com
April 27, 2017
New research suggests additional evidence that Parkinson's disease may originate in the gut.
-
Hitachi elected by Sumitomo Dainippon Pharma for Automated Culture Equipment
biospectrumasia
April 14, 2017
Research equipment for the manufacturing cells used in Parkinson's disease treatment
-
Zambon launches Xadago in Portugal to treat Parkinson’s disease
pharmaceutical-technology
April 12, 2017
Italian pharmaceutical company Zambon and its partner Newron Pharmaceuticals have launched Xadago (safinamide) in ...
-
FDA Approves New Drug as Add-On Treatment for Parkinson's
dddmag
March 24, 2017
U.S. regulators have approved the first new drug in a decade for Parkinson's disease, a chronic neurological disorder that causes tremors and movement difficulties.
-
FDA OK’s first novel treatment for Parkinson’s in ten years
pharmatimes
March 23, 2017
The US Food and Drug Administration has approved the first novel treatment option in more than a decade for patients...
-
Success for Renown’s Phase I study to treat “OFF” episodes in Parkinson’s patients
europeanpharmaceuticalreview
March 23, 2017
Renown Pharma’s pharmacokinetic study demonstrated safety and tolerability.
-
Keapstone Therapeutics and Sygnature Discovery Collaborate
contractpharma
March 15, 2017
Will work to discover new therapies for Parkinson’s and Motor Neuron Disease
-
Parkinson’s UK, Sheffield University launch virtual biotech
pharmatimes
March 09, 2017
The University of Sheffield and Parkinson’s UK have launched a new £1-million virtual biotech company as part of a research programme to create novel medicines for Parkinson’s disease.
-
Keapstone Therapeutics created out of Sheffield Uni and Parkinson’s UK link
pharmafile
March 09, 2017
The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual biotech company for d...
-
Could Parkinson's Disease Raise Stroke Risk?
drugs.com
February 24, 2017
A large new analysis suggests there may some type of link between Parkinson's disease and the risk for stroke.